ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period

October 18, 1985

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

Gore Proposes New War On cancer, Double research Funding Over 5 years

July 9, 1999

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

In Brief: NBCC Honors D’Amato, Leahy, Mack, Stevens; Center Development Officers Elect Leaders

May 8, 1998

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012